So who is Dr. Zain Khapley exactly?
Well in March 2013 Heart Surgeon Zain Khalpey Appointed to Lead Heart Transplant Program & Mechanical Circulatory Support Surgery Program at UAMC.
Dr. Khalpey is engaged in ex vivo reconditioning of marginal human hearts and lungs, which will generate functional lung and heart tissue that ultimately can be used for transplantation. This reconditioning process uses human cadaveric lungs that are decellularized (chemically stripped of its cells, leaving behind the extracellular tissue and lung scaffolds). That structure is “re-seeded” with autologous stem cells to rebuild the organ.
He also is involved in creating clinical “bridge-to-regeneration” trials, in which autologous stem cells (SVFC comes into play) will be injected into failing hearts with the hope of recovery in an era of limited hearts for transplantation.
What has Dr. Khapley been working on since March?
Jun 17, 2013 (ACCESSWIRE via COMTEX) -- NEW YORK, NY June 17, 2013 / -- IntelliCell BioSciences, Inc. ("Company") (otc pink:SVFC) announced today that Dr Zain Khalpey, MD, PhD, MRCS (Eng) Director, Heart Transplant Program & Mechanical Circulatory Support, Division of Cardiothoracic Surgery?Associate Professor of Surgery, Physiological Sciences & Biomedical Engineering, University of Arizona College of Medicine has joined the Advisory Board.
Dr. Khapley has brought all of his knowledge to Intellicell to sit on our Board of Directors.
This is huge!!! Can't wait for developments at SVFC.
AI
